1. Home
  2. Analysis
  3. Carbamazepine
  4. Hyperphosphataemia

Carbamazepine and Hyperphosphataemia - a phase IV clinical study of FDA data

Summary:

Hyperphosphataemia is reported as a side effect among people who take Carbamazepine (carbamazepine), especially for people who are male, 10-19 old, also take Tetrabenazine, and have Movement disorder.

The phase IV clinical study analyzes which people have Hyperphosphataemia when taking Carbamazepine. It is created by eHealthMe based on reports of 43,715 people who have side effects when taking Carbamazepine from the FDA, and is updated regularly.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 44,628 Carbamazepine users. Check the latest studies of Carbamazepine.

What is Hyperphosphataemia?

Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood) is found to be associated with 429 drugs and 377 conditions by eHealthMe. Check the latest studies of Hyperphosphataemia.

On Jul, 07, 2026

43,715 people reported to have side effects when taking Carbamazepine.
Among them, 18 people (0.04%) have Hyperphosphataemia.

Could Carbamazepine cause Hyperphosphataemia?

Among these 18 people:

What is the gender of people who have Hyperphosphataemia when taking Carbamazepine? *

  • female: 35.29 %
  • male: 64.71 %

What is the age of people who have Hyperphosphataemia when taking Carbamazepine? *

  • 0-1: 0.0 %
  • 2-9: 5.88 %
  • 10-19: 64.71 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 5.88 %
  • 50-59: 5.88 %
  • 60+: 17.65 %

What are other drugs people take besides Carbamazepine? *

  1. Baclofen: 10 people, 55.56%
  2. Clobazam: 10 people, 55.56%
  3. Tetrabenazine: 10 people, 55.56%
  4. Midazolam: 9 people, 50.00%
  5. Diazepam: 9 people, 50.00%
  6. Clonidine: 8 people, 44.44%
  7. Morphine: 7 people, 38.89%
  8. Furosemide: 4 people, 22.22%
  9. Morphine Sulfate: 3 people, 16.67%
  10. Depakene: 2 people, 11.11%

What are other side effects people have besides Hyperphosphataemia? *

  1. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 11 people, 61.11%
  2. Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 10 people, 55.56%
  3. Hypotension (abnormally low blood pressure): 10 people, 55.56%
  4. Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body): 9 people, 50.00%
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 9 people, 50.00%
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 7 people, 38.89%
  7. Hyporeflexia (a condition of below normal or absent reflexes): 2 people, 11.11%
  8. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 11.11%
  9. Osteomalacia (softening of the bones due to a lack of vitamin d): 2 people, 11.11%
  10. Osteopathy: 2 people, 11.11%

What are the existing conditions these people have? *

  1. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 9 people, 50.00%
  2. Movement - Uncontrolled Or Slow: 5 people, 27.78%
  3. Dyskinesia (abnormality or impairment of voluntary movement): 5 people, 27.78%
  4. Hypervolaemia (abnormally increased volume of blood): 3 people, 16.67%
  5. Sedation: 2 people, 11.11%
  6. Upper Respiratory Tract Infection: 1 person, 5.56%
  7. Fever: 1 person, 5.56%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.56%
  9. Calcium Deficiency (lack of calcium): 1 person, 5.56%
  10. Constipation: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Carbamazepine and have Hyperphosphataemia?

- Check whether Hyperphosphataemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carbamazepine:

Hyperphosphataemia treatments and more:

How severe was Hyperphosphataemia and when was it recovered:

Expand to all the drugs that have ingredients of carbamazepine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperphosphataemia:

Browse all the conditions that are associated with Hyperphosphataemia:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Carbamazepine) and Carbamazepine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.